v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (28,952) $ (273,115)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 24,626 23,966
Amortization of leases 721 720
Amortization of deferred financing costs 474 485
Equity-based compensation 9,085 22,403
Loss on asset disposals 86 196
Change in fair value of derivative asset 338 573
Deferred income tax expense (benefit) (403) 76,707
Non-cash interest expense - net 269 334
Change in fair value of Intermediate Warrants 1,469 (3,574)
Change in fair value of Intermediate Warrants 0 (4,849)
Loss on extinguishment of debt 0 801
Adjustment of liabilities under TRA 0 (149,172)
Impairment charges 0 320,449
Write-off of Sponsorship Loan 0 2,024
Changes in operating assets and liabilities:    
Accounts receivable - net (14,520) (906)
Inventory - net (8,764) (13,018)
Prepaid expenses and other current assets (12,869) 3,613
Accounts payable 77,670 (29,394)
Accrued expenses and other current liabilities (243) (28,104)
Deferred revenue (2,643) (3,826)
Long-term lease liabilities (1,183) (1,085)
Other assets and liabilities - net 47 864
Net cash provided by (used in) operating activities 45,208 (53,908)
Cash flows from investing activities    
Purchases of property and equipment (23) (2,043)
Purchases of personal seat licenses (625) (960)
Investments in developed technology (5,993) (8,341)
Purchases of seat images (287) (321)
Net cash used in investing activities (6,928) (11,665)
Cash flows from financing activities    
Payments of taxes related to net settlement of equity incentive awards (686) (1,742)
Payments toward Acquired Domain Name Obligation (1,000) (1,000)
Repurchases of Class A common stock 0 (15,862)
Payments of liabilities under TRA 0 (4,005)
Proceeds from 2025 First Lien Loan 0 76,986
Payment of deferred financing costs and other debt-related expenses 0 (162)
Tax distributions to redeemable noncontrolling interests 0 (1,689)
Net cash used in financing activities (3,651) (25,443)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (355) 354
Net increase (decrease) in cash, cash equivalents, and restricted cash 34,274 (90,662)
Cash, cash equivalents, and restricted cash - beginning of period 103,306 244,648
Cash, cash equivalents, and restricted cash - end of period 137,580 153,986
Supplemental disclosures of cash flow information    
Cash paid for interest 12,086 14,883
Cash paid for income taxes, net of income tax refunds received 268 1,953
Cash paid for operating lease liabilities 1,830 1,706
Equity-based compensation expense related to capitalized development costs 221 370
Deferred Financing Costs and Other Debt-Related Expenses Recorded In Accrued Expenses and Other Current Liabilities 798 0
Repurchases of Class A common stock recorded in Accrued expenses and other current liabilities 0 275
2024 First Lien Loan    
Cash flows from financing activities    
Payments of Loan 0 (76,986)
2025 First Lien Loan    
Cash flows from financing activities    
Payments of Loan $ (1,965) $ (983)